Followers

Saturday, October 25, 2008

Half of Doctors Routinely Prescribe Placebos

By GARDINER HARRIS

Half of all American doctors responding to a nationwide survey say they regularly prescribe placebos to patients. The results trouble medical ethicists, who say more research is needed to determine whether doctors must deceive patients in order for placebos to work.

The study involved 679 internists and rheumatologists chosen randomly from a national list of such doctors. In response to three questions included as part of the larger survey, about half reported recommending placebos regularly. Surveys in Denmark, Israel, Britain, Sweden and New Zealand have found similar results.

The most common placebos the American doctors reported using were headache pills and vitamins, but a significant number also reported prescribing antibiotics and sedatives. Although these drugs, contrary to the usual definition of placebos, are not inert, doctors reported using them for their effect on patients’ psyches, not their bodies.

In most cases, doctors who recommended placebos described them to patients as “a medicine not typically used for your condition but might benefit you,” the survey found. Only 5 percent described the treatment to patients as “a placebo.”

The study is being published in BMJ, formerly The British Medical Journal. One of the authors, Franklin G. Miller, was among the medical ethicists who said they were troubled by the results.

“This is the doctor-patient relationship, and our expectations about being truthful about what’s going on and about getting informed consent should give us pause about deception,” said Dr. Miller, director of the research ethics program in the department of bioethics at the National Institutes of Health.

Dr. William Schreiber, an internist in Louisville, Ky., at first said in an interview that he did not believe the survey’s results, because, he said, few doctors he knows routinely prescribe placebos.

But when asked how he treated fibromyalgia or other conditions that many doctors suspect are largely psychosomatic, Dr. Schreiber changed his mind. “The problem is that most of those people are very difficult patients, and it’s a whole lot easier to give them something like a big dose of Aleve,” he said. “Is that a placebo treatment? Depending on how you define it, I guess it is.”

But antibiotics and sedatives are not placebos, he said.

The American Medical Association discourages the use of placebos by doctors when represented as helpful.

“In the clinical setting, the use of a placebo without the patient’s knowledge may undermine trust, compromise the patient-physician relationship and result in medical harm to the patient,” the group’s policy states.

Controlled clinical trials have hinted that placebos may have powerful effects. Some 30 percent to 40 percent of depressed patients who are given placebos get better, a treatment effect that antidepressants barely top. Placebos have also proved effective against hypertension and pain.

But despite much attention given to the power of placebos, basic questions about them remain unanswered: Are they any better than no treatment at all? Must people be deceived into believing that a treatment is active for a placebo to work?

Some studies have hinted at answers, but experts say far more work is needed.

Dr. Howard Brody, director of the Institute for the Medical Humanities at the University of Texas Medical Branch, in Galveston, said the popularity of alternative medical treatments had led many doctors to embrace placebos as a potentially useful tool. But, Dr. Brody said, doctors should resist using placebos, because they reinforce the deleterious notion that “when something is the matter with you, you will not get better unless you swallow pills.”

Earlier this year, a Maryland mother announced that she would start selling dextrose tablets as a children’s placebo called Obecalp, for “placebo” spelled backward.

Dr. Ezekiel J. Emanuel, one of the study’s authors, said doctors should not prescribe antibiotics or sedatives as placebos, given those drugs’ risks. Use of less active placebos is understandable, he said, since risks are low.

“Everyone comes out happy: the doctor is happy, the patient is happy,” said Dr. Emanuel, chairman of the bioethics department at the health institutes. “But ethical challenges remain.”

Original here

Fighter jet engine to power 1000 mph car

By Wolfgang Gruener

If you have a budget of about $1.5 million and some patience, you can purchase the world’s fastest production car, the Bugatti Veyron 16.4, and brag about a top speed slightly north of 250 mph. But even that insane speed (which can only achieved with a special key and typically only on closed circuits) is well below the current land speed record of 763 mph, which was achieved by a jet-powered car called Thrust SSC in 1997. 14 years later, the same driver, Andy Green, as well as a previous record holder, Richard Noble, will try to break the 1000 mph barrier with Bloodhound SSC (SSC stands for super sonic car) in a project that is financed by the British Ministry of Defence.



Image


The vehicle is about 42 ft long, weighs 14,158 pounds (fuelled) and is expected to accelerate from 0 – 1050 mph in 40 seconds. At that speed, 900mm diameter wheels will spin at over 10,000rpm, generating 50,000 radial g at the rim. Every second, the vehicle will cover a distance of 1466 feet, which is the equivalent of nearly 5 football fields. The downforce pressure on its carbon fiber and titanium bodywork will exceed 2450 pounds per square foot or more than 12 tons per square meter.

Today’s project launch is followed by a week-long exhibition at the Science Museum, London, where the public can meet the team.


Challenges

Bloodhound SSC faces two key challenges – to create tires that will hold on at 1000 mph and are not damaged by surface inconsistencies, as well a power plant that will drive the vehicle to a top speed of more than 1000 mph. Deeply involved in the project are scientists at the UK's National Physical Laboratory (NPL) as well as colleagues at the Atomic Weapons Establishment (AWE) and Fluid Gravity Engineering (FGE) units “to advise the world-record bid team on two of the most high-risk aspects of the world record attempt.”

The scientists said the wheels need to be able to rotate at 10,500 rpm without being damaged by the surface or any stones that they run over. They also need to be as light as possible to minimize steering and suspension forces, absorb all of the weight, down force loads and stresses and distribute this pressure without causing damage to the vehicle or the surface. The choice of materials, including titanium, aluminum alloys and metal composites are currently evaluated because at such speeds the wheels act like powerful gyroscopes.


Power plant

The power will come from the first ever mixed power plant of a hybrid rocket motor and a jet engine that is currently used on the Eurofighter Typhoon. The Eurojet EJ200 afterburning turbofan provides a thrust of 60 kN or 13,500 lbs and 90 kN or 22,000 lbs with afterburner, which would be enough to lift the Bloodhound SSC vertically off the ground like a rocket. Equipped with two engines, the Eurofighter jet is capable of reaching a top speed of about 1320 mph or Mach 2.

When completed, the Bloodhound SSC (super sonic car) will be driven by Andy Green who set the current record of 763 mph. If the new vehicle achieves its target of 1,000 mph, it will mark the greatest incremental increase in the history of the World Land Speed Record. It will also exceed the low altitude speed record for aircraft (994 mph), the developers said. Richard Noble who set a land speed record with Thrust 2 and 633 mph in 1983, was appointed project leader for Bloodhound SSC.


Big objective - education

The organization said that it is primary objective of the project is to “create an unprecedented education and engagement program, lead led by a dedicated team of teachers and education specialists.”

“From innovative, curriculum based lesson plans covering subjects ranging from geography to citizenship, as well as science, technology, engineering and mathematics, to a schools visitor centre featuring the ‘classroom of the future’ at the team’s HQ in Filton, Bristol, the aim is to make Bloodhound SSC accessible to all ages from 5 – 19 and beyond,” the group stated.

Original here

Banksy defies the credit crisis as his canvases fetch over £350,000 at auction

Banksy's Tesco Value Tomato Soup. The graffiti artist has defied the credit crisis with a sale of his canvases fetching more than £350,000 at auction.
The Tomato Soup picture fetched £140,000 Photo: PA

One oil canvas, entitled Tesco Value Tomato Soup, fetched £140,000, more than the estimated £80,000, according to Bonhams, the auction house.

A spokeswoman said: "A bidding war broke out for it. It was jam-packed in the auction room but it was soon whittled down to two contenders" she said "All the big lots were sold."

The picture was among 24 of Banksy's best-known original works which came under the hammer last night.

Banksy came to prominence in his home city of Bristol for spray-can murals that commented on issues like law and order, consumerism and war - all in a in a playful fashion.

His famous picture of a chimp wearing a sign saying 'Laugh now but one day we'll be in charge' went under the hammer for £108,000.

A picture of Kate Moss in a Marilyn Monroe-style pose fetched £66,000. And his work 'Turf War', featuring Winston Churchill with a green mohawk haircut, sold for £60,000.

However, a life-sized stencil of a riot police officer with a smiley face entitled 'Have a Nice Day' - failed to sell.

Despite Banksy's popularity, he has zealously guarded his anonymity which has fuelled speculation about his real identity.

High profile collectors include Dennis Hopper, the actor, and Angelina Jolie, the actress, who spent £1 million on a piece last year.

The success of the sale will be reassuring for the art markets which has been severely hit by the financial crisis, with Sotheby's and Christie's, auctioneers, both reporting disappointing sales.

Sotheby's failed to reach its estimate of £55.3 million for its contemporary art sales over the summer, making a total of £43.9 million.

Original here